RxDoctor Payments Data
★ My doctorsLook up a doctor →

Lorin Brandon, DPM

Podiatrist · Taos, NMNPI 1710016241

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. Stryker accounts for 82.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $6,783 and has fallen 82.2% since, to $1,209 in 2025. Among podiatrist clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,878in general payments, 2019–2025

Across 239 payments — averaging $74.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$15K
  • Zimmer Biomet$978
  • Smith+Nephew$622
  • Crossroads Extremity Systems, LLC$480
  • Bioventus LLC$160
  • Abbott$147
  • plus $794 from 14 others

What the payments were for

  • Travel & lodging$8,68849%
  • Food & beverage$9,08951%
  • Education$1011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker182$14,696
Zimmer Biomet10$978
Smith+Nephew20$622
Crossroads Extremity Systems, LLC3$480
Bioventus LLC2$160
Abbott1$147
Mimedx Group, Inc.1$133
Amgen1$125
Rikco International, LLC4$123
Cook Medical LLC1$111
Medtronic1$105
Organogenesis Inc.3$53
Paratek Pharmaceuticals, Inc.2$32
Heron Therapeutics, Inc.2$28
Treace Medical Concepts, Inc.1$27
Johnson & Johnson1$15
Averitas Pharma Inc.1$14
Nevro Corp.1$13
Advanced Oxygen Therapy Inc.1$8
Orthofix Medical, Inc.1$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,878 in reported general payments places this provider in the 90th percentile of 46 podiatrist providers in New Mexico.

See all podiatrist providers in New Mexico →

Medicare billing

Part B allowed, 2024
$180,338
Medicare patients
458
Services billed
3,840

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip29$1,157
Methylprednisolone46$363
Gabapentin31$238
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$76

Paid to pharmacies, not to this prescriber.

Other podiatrist in Taos

See the full list for New Mexico →

Where these figures come from

Is this you, or does something look wrong? →